Lapatinib for treatment of advanced or metastasized breast cancer: systematic review

CONTEXT AND OBJECTIVE: Around 16% to 20% of women with breast cancer have advanced, metastasized breast cancer. At this stage, the disease is treatable, but not curable. The objective here was to assess the effectiveness of lapatinib for treating patients with advanced or metastasized breast cancer....

Full description

Bibliographic Details
Main Authors: Rachel Riera, Patrícia Coelho de Soárez, Maria Eduarda dos Santos Puga, Marcos Bosi Ferraz
Format: Article
Language:English
Published: Associação Paulista de Medicina
Series:São Paulo Medical Journal
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-31802009000500009&lng=en&tlng=en